 |
Top 10 Genome Analysis startups
Updated: April 19, 2024 |
Genome analysis startups are at the forefront of genomic medicine, developing advanced technologies and tools to analyze and interpret genetic information on a large scale. These startups aim to revolutionize healthcare by leveraging genomic data to enable personalized medicine, identify disease risks, and guide treatment decisions based on an individual's unique genetic profile, ultimately leading to more precise diagnostics, targeted therapies, and improved health outcomes for patients.
1
Country: USA | Funding: $2B
Pacific Biosciences designs, develops, and manufactures sequencing systems to resolve genetically complex problems.
Pacific Biosciences designs, develops, and manufactures sequencing systems to resolve genetically complex problems.
2
Country: UK | Funding: £1.1B
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
3
Country: USA | Funding: $1.1B
23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards.
23andMe is the first and only genetic service available directly to you that includes reports that meet FDA standards.
4
Country: USA | Funding: $1.1B
Freenome is a platform that helps design healthy conditions for an individual based on his/her cell-free genome. It employs Artificial Intelligence to detect colorectal cancer.
Freenome is a platform that helps design healthy conditions for an individual based on his/her cell-free genome. It employs Artificial Intelligence to detect colorectal cancer.
5
Country: USA | Funding: $925.9M
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.
6
Country: USA | Funding: $901.8M
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.
7
Country: USA | Funding: $890.7M
A simple blood test unlocks a new dimension in cancer management. Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time and identifies associated treatment options.
A simple blood test unlocks a new dimension in cancer management. Guardant360 is the only biopsy-free tumor sequencing test that tracks tumor genomics in real-time and identifies associated treatment options.
8
Country: USA | Funding: $603.3M
Fulcrum Therapectics to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. By focusing on disease causative genes, we are taking a highly personalized approach to treating disease – unlocking the druggable mechanisms that regulate disease genes to develop a new generation of disease-modifying therapies.
Fulcrum Therapectics to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. By focusing on disease causative genes, we are taking a highly personalized approach to treating disease – unlocking the druggable mechanisms that regulate disease genes to develop a new generation of disease-modifying therapies.
9
Country: USA | Funding: $600M
Ultima Genomics is unleashing the power of genomics at scale.
Ultima Genomics is unleashing the power of genomics at scale.
10
Country: USA | Funding: $497M
Color provides a high-quality, physician-ordered, genetic test at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to genetic testing for hereditary cancer risk to every person, everywhere.
Color provides a high-quality, physician-ordered, genetic test at a low cost. We include support for physicians, as well as genetic counseling as part of every purchase. Our goal is to expand physician-supported access to genetic testing for hereditary cancer risk to every person, everywhere.
Ad
Advertise your startup
11
Country: USA | Funding: $472.6M
DNAnexus combines expertise in cloud computing and Bioinformatics to create a global network for genomic medicine.
DNAnexus combines expertise in cloud computing and Bioinformatics to create a global network for genomic medicine.
12
Country: USA | Funding: $403M
At Helix, we’re dedicated to making DNA learning accessible and actionable for everyone. It’s our mission to empower every person to improve their life through DNA. We believe in a world where everyone benefits from their biological information and is able to help all of humanity lead better lives.
At Helix, we’re dedicated to making DNA learning accessible and actionable for everyone. It’s our mission to empower every person to improve their life through DNA. We believe in a world where everyone benefits from their biological information and is able to help all of humanity lead better lives.
13
Country: USA | Funding: $340.5M
Human Longevity is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
Human Longevity is the genomics-based, technology-driven company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
14
Country: USA | Funding: $337.3M
CardioDx is a cardiovascular genomic diagnostics company located in Redwood City, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
CardioDx is a cardiovascular genomic diagnostics company located in Redwood City, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure.
15
Country: USA | Funding: $254M
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health.
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health.
16
Country: Switzerland | Funding: $250.2M
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
Sophia Genetics aims to bring data analytics solutions to the market, to support healthcare professionals by maximizing the power of data-driven medicine. It achieves this mission through the adoption of SOPHiA AI, which is built using techniques such as statistical inference, pattern recognition, and machine learning.
17
Country: USA | Funding: $244.7M
Our services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Our expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. We specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.
Our services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Our expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. We specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer.
18
Country: USA | Funding: $225.1M
Personalis provides researchers and clinicians accurate DNA sequencing and interpretation of human exomes and genomes. We support researchers engaging in case-control, family-based, or proband-only genomic studies of disease, pharmacogenomics, and cancer. Our ACE (Accuracy and Content Enhanced) Technology supplements a standard exome or genome, substantially increasing its medically-relevant coverage and accuracy.
Personalis provides researchers and clinicians accurate DNA sequencing and interpretation of human exomes and genomes. We support researchers engaging in case-control, family-based, or proband-only genomic studies of disease, pharmacogenomics, and cancer. Our ACE (Accuracy and Content Enhanced) Technology supplements a standard exome or genome, substantially increasing its medically-relevant coverage and accuracy.
19
Country: USA | Funding: $221.7M
Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs and HAIs, where rapid diagnosis is essential for effective treatment and control.
Our pioneering, flexible diagnostic instrument and disposable cartridge system is designed for decentralised laboratory, point-of–care and other near-patient settings. It provides a fast, easy-to-use and accurate affordable solution to screening for the presence of STIs and HAIs, where rapid diagnosis is essential for effective treatment and control.
20
Country: China | Funding: $200M
iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
iCarbonX aims to build an ecosystem of digital life based on a combination of an individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.
21
Country: Hong Kong | Funding: $187.7M
We are a rapidly growing DNA Biotechnology company specializing in Pharmacogenomics. Our proprietary technology enables physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADE’s), based on one’s genetic profile. Our vision is to improve quality of life, prevent ADE’s and to save on healthcare costs by providing the tools essential for personalized medication management.
We are a rapidly growing DNA Biotechnology company specializing in Pharmacogenomics. Our proprietary technology enables physicians to help patients identify the right drug, right dosage and to list out potential adverse drug effects (ADE’s), based on one’s genetic profile. Our vision is to improve quality of life, prevent ADE’s and to save on healthcare costs by providing the tools essential for personalized medication management.
22
Country: UK | Funding: $155.2M
Cambridge Epigenetix develops ground-breaking epigenetics tools for DNA methylation (5mC) and hydroxymethylation (5hmC) analysis.
Cambridge Epigenetix develops ground-breaking epigenetics tools for DNA methylation (5mC) and hydroxymethylation (5hmC) analysis.
23
Country: USA | Funding: $134.1M
We use genomic data to find better drugs, faster. We find new cures for brain diseases 1000X more cheaply and quickly using our proven network algorithms.
We use genomic data to find better drugs, faster. We find new cures for brain diseases 1000X more cheaply and quickly using our proven network algorithms.
24
Country: USA | Funding: $112M
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
C2i Genomics provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.
25
Country: USA | Funding: $108M
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
26
Country: USA | Funding: $100.5M
Variantyx offers a comprehensive set of advanced genomic diagnostic products and services with a focus on whole genome sequencing.
Variantyx offers a comprehensive set of advanced genomic diagnostic products and services with a focus on whole genome sequencing.
27
Country: USA | Funding: $96.5M
Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease. We bring a pan-cancer orientation to the treatment of both solid tumors and hematologic cancers, and help make precision medicine a reality for patients by providing comprehensive genomic profiles to oncologists to help them match their patients to targeted therapies.
Foundation Medicine is leading a transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease. We bring a pan-cancer orientation to the treatment of both solid tumors and hematologic cancers, and help make precision medicine a reality for patients by providing comprehensive genomic profiles to oncologists to help them match their patients to targeted therapies.
28
Country: Nigeria | Funding: $94.7M
54gene is a healthcare startup that offers a genetics testing platform.
54gene is a healthcare startup that offers a genetics testing platform.
29
Country: USA | Funding: $76.2M
Recent scientific breakthroughs are revolutionizing the way we think about DNA and health. Orig3n is on a mission to turn these discoveries into practical solutions and make them available to you.
Recent scientific breakthroughs are revolutionizing the way we think about DNA and health. Orig3n is on a mission to turn these discoveries into practical solutions and make them available to you.
30
Country: India | Funding: $74M
PierianDx solves the problem of translating complex genomic data into actionable clinical insight to advance precision medicine. We do this through a cloud-based clinical genomics software platform that simplifies the process of taking DNA sequencing data though analysis, interpretation and final report. This is made possible through Actionable Intelligence derived from our comprehensive knowledgebase supplemented by human clinical expertise.
PierianDx solves the problem of translating complex genomic data into actionable clinical insight to advance precision medicine. We do this through a cloud-based clinical genomics software platform that simplifies the process of taking DNA sequencing data though analysis, interpretation and final report. This is made possible through Actionable Intelligence derived from our comprehensive knowledgebase supplemented by human clinical expertise.
31
Country: USA | Funding: $73M
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
OncoCyte focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
32
Country: UK | Funding: $70.6M
Lifebit is building the world’s first intelligent genomics platform that understands DNA data and generates meaningful insights like humans do.
Lifebit is building the world’s first intelligent genomics platform that understands DNA data and generates meaningful insights like humans do.
33
Country: USA | Funding: $65.4M
Mendel.ai automates matching cancer patients to clinical trials through personal medical history and genetic analysis.
Mendel.ai automates matching cancer patients to clinical trials through personal medical history and genetic analysis.
34
Country: USA | Funding: $61.4M
Veritas Genetics is the first company in medical history to offer individuals the opportunity to easily and affordably unlock the secrets of their entire genome. To know what truly, scientifically makes us tick, and to be able to put this knowledge to work each and every day.
Veritas Genetics is the first company in medical history to offer individuals the opportunity to easily and affordably unlock the secrets of their entire genome. To know what truly, scientifically makes us tick, and to be able to put this knowledge to work each and every day.
35
Country: USA | Funding: $55M
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
Replay is a genome writing company reprogramming biology by writing and delivering big DNA.
36
Country: Japan | Funding: $34.3M
Quantum Biosystems is developing single-molecule electrical sequencing of DNA and applies quantum mechanics to the field of genome sequencing. Quantum Biosystem's methodology does not use reagents, proteins and other materials that make genome sequencing an expensive affair. Its sequencers are nano chips that are essentially silicon semiconductor chips in that they can be mass produced.
Quantum Biosystems is developing single-molecule electrical sequencing of DNA and applies quantum mechanics to the field of genome sequencing. Quantum Biosystem's methodology does not use reagents, proteins and other materials that make genome sequencing an expensive affair. Its sequencers are nano chips that are essentially silicon semiconductor chips in that they can be mass produced.
37
Country: USA | Funding: $29M
We are past Human Genome Project Scientists that are developing the next generation of diagnostics and disease monitoring tests for the 95% of diseases that cannot be diagnosed by DNA. We are on a war-path to advance drug development and clinical diagnostics through our unique RNA tests.
We are past Human Genome Project Scientists that are developing the next generation of diagnostics and disease monitoring tests for the 95% of diseases that cannot be diagnosed by DNA. We are on a war-path to advance drug development and clinical diagnostics through our unique RNA tests.
38
Country: France | Funding: €23M
SeqOne is a next generation genomic analysis for next generation healthcare.
SeqOne is a next generation genomic analysis for next generation healthcare.
39
Country: USA | Funding: $23.8M
Massive Bio brings cancer genomics to the masses, to improve quality of care and minimize costs.
Massive Bio brings cancer genomics to the masses, to improve quality of care and minimize costs.
40
Country: Israel | Funding: $20M
Genoox is a revolutionary big data platform for storing and managing genomic data in the cloud. Their platform is designed and optimized specifically for genomic data - it reduces the complexity and costs attached with genomic data management.
Genoox is a revolutionary big data platform for storing and managing genomic data in the cloud. Their platform is designed and optimized specifically for genomic data - it reduces the complexity and costs attached with genomic data management.
41
Country: USA | Funding: $17.5M
Nucleus combines genetic and non-genetic information and calculates the absolute risk scores for people for disease.
Nucleus combines genetic and non-genetic information and calculates the absolute risk scores for people for disease.
42
Country: USA | Funding: $16.5M
Genomic Prediction provides advanced genomic tests which improve IVF health outcomes.
Genomic Prediction provides advanced genomic tests which improve IVF health outcomes.
43
Country: USA
Your unique DNA profile can give you a lot of information about your health— but many consumers are left wondering what to do with that information. That’s where we come in. At Toolbox Genomics, our mission is to give you practical and actionable food & lifestyle recommendations based on your DNA.
Your unique DNA profile can give you a lot of information about your health— but many consumers are left wondering what to do with that information. That’s where we come in. At Toolbox Genomics, our mission is to give you practical and actionable food & lifestyle recommendations based on your DNA.
44
Country: USA | Funding: $14.4M
20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer.
20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer.
45
Country: India | Funding: $13M
Strand Life Sciences uses genomic profiling based on next-generation sequencing (NGS) technology to improve the care of cancer.
Strand Life Sciences uses genomic profiling based on next-generation sequencing (NGS) technology to improve the care of cancer.
46
Country: USA
TDx is a molecular diagnostic and precision medicine company focused on developing clinically useful lab tests that guide treatment decisions for better outcomes initially in oncology.
TDx is a molecular diagnostic and precision medicine company focused on developing clinically useful lab tests that guide treatment decisions for better outcomes initially in oncology.
47
Country: USA | Funding: $11.4M
Cambrian Genomics makes the first hardware/systems for laser printing DNA. Researchers in academia & industry order or clone >$1b/year of DNA. CGI delivers high quality sequence verified DNA to buyers in this existing/growing worldwide market.
Cambrian Genomics makes the first hardware/systems for laser printing DNA. Researchers in academia & industry order or clone >$1b/year of DNA. CGI delivers high quality sequence verified DNA to buyers in this existing/growing worldwide market.
48
Country: USA | Funding: $10.6M
The world's First and Only Personalization Platform for Health and Wellness Products and Services Tailored to Your DNA and Lifestyle.
The world's First and Only Personalization Platform for Health and Wellness Products and Services Tailored to Your DNA and Lifestyle.
49
Country: USA | Funding: $10.3M
Next-generation sequencing and other high-throughput genomic measurement technologies are providing us with unprecedented visibility into the origins of health and disease. Understanding these datasets has the potential to create a paradigm shift in how we develop drugs, diagnose disease, prevent ailments, and treat patients, especially in complex cases such as cancer.
Next-generation sequencing and other high-throughput genomic measurement technologies are providing us with unprecedented visibility into the origins of health and disease. Understanding these datasets has the potential to create a paradigm shift in how we develop drugs, diagnose disease, prevent ailments, and treat patients, especially in complex cases such as cancer.
50
Country: Indonesia | Funding: $8.2M
Asaren is a genetic platform that provides a holistic approach to medical genetics.
Asaren is a genetic platform that provides a holistic approach to medical genetics.